This could suggest that the effect of Slc11a2 knockdown is primarily on select DAM-related markers and not on iron markers per se, or it could reflect a time-dependent transcriptional change in those markers during AD progression that was not captured at the time point tested. This evidence concerns the gene SLC11A2 and Alzheimer disease.